Several specialized organizations worldwide focus on the production of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant challenges in process development due to their molecular intricacy. The manufacturers of these APIs often employ sophisticated methods and adhere to strict regul